Status: Phase 3
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Fibromyalgia; Myofascial Pain Syndromes Phase 3 ClinicalTrials
Fibromyalgia; Myofascial Pain Syndromes Phase 3 ClinicalTrials
Diabetic Neuropathies; Neuralgia; Neuralgia, Postherpetic; Renal Insufficiency Phase 3 ClinicalTrials
Diabetic Neuropathies; Peripheral Nervous System Diseases Phase 2 ClinicalTrials
Diabetic Neuropathies; Neuralgia Phase 3 ClinicalTrials
Fibromyalgia; Kidney Diseases; Myofascial Pain Syndromes; Renal Insufficiency, Chronic Phase 3 ClinicalTrials
Fibromyalgia; Myofascial Pain Syndromes Phase 3 ClinicalTrials
Fibromyalgia; Myofascial Pain Syndromes Phase 3 ClinicalTrials
CONTENTS